Patient decision aids in clinical practice for people with diabetes: a scoping review
- PDF / 1,010,426 Bytes
- 16 Pages / 595.276 x 790.866 pts Page_size
- 16 Downloads / 168 Views
REVIEW ARTICLE
Patient decision aids in clinical practice for people with diabetes: a scoping review Jodie Cornelius1 · Frances Doran2 · Elaine Jefford2 · Nasim Salehi2 Received: 16 December 2019 / Accepted: 2 March 2020 © The Japan Diabetes Society 2020
Abstract Background People with diabetes need to make regular choices that influence their long-term morbidity and mortality. Patient decision aids are validated tools and when used collaboratively between healthcare professionals, patients and carers, can help guide value-based discussions which encourage choices that are well informed and personally relevant. Objective To explore the use and effect of patient decision aids in the management of diabetes. Method A scoping review design was used. Medline, ProQuest, PsycINFO, Scopus, and Cumulative Index to Nursing and Allied Health Literature databases were searched for peer-reviewed articles published between January 1998 and December 2018. Results Patient decision aids are not commonly or widely used in diabetes management. They offer a suitable adjunct to practice within the domains of healthcare knowledge, active participation, and communication, and shared decision-making between patients and healthcare professionals. Conclusion Patient decision aids can offer a simple and easy-to-use method to potentially improve diabetes health literacy, through the process of shared decision-making and two-way conversations. However, there are current limitations on using them to positively influence clinical outcomes or long-term changes in self-care behaviors within the management of diabetes. Further research to explore the validity of using patient decision aids long term in these areas is required. Keywords Diabetes · Patient decision aid(s) · Shared decision-making · Health education · Patient choice
Introduction Diabetes is a twenty-first century worldwide epidemic [1, 2] with prevalence rates overtaking all other chronic conditions [3], and an estimate of 438 million people (or 1:10) affected by 2030 [4, 5]. Currently, ranked the fourth leading cause of death, diabetes contributes to a 6.8% worldwide mortality rate, which if effective action is not pursued will rise by 50% within 10 years [5]. Diabetes is associated with financial and
Electronic supplementary material The online version of this article (https://doi.org/10.1007/s13340-020-00429-7) contains supplementary material, which is available to authorized users. * Jodie Cornelius [email protected] 1
Bendigo Health, P.O Box 126, Bendigo, VIC 3550, Australia
School of Health and Human Sciences, Southern Cross University, Lismore, NSW 2480, Australia
2
personal implications [6] with global health expenditure of around $673 billion annually (or 12% of GDP) [7]. For individuals, the burden of diabetes includes an increased probability of co-morbidities such as disability, reduced lifespan, and quality of life (50–80%) [8]. Despite adherence to treatment at a level of 50% in the developed world [9], education and self-manage
Data Loading...
